Biotech | April 01, 2022
Premas Life Sciences to handle Beckman’s liquid handling solutions in India
Through this partnership, Premas will connect with genomics labs to provide automated NGS solutions
Through this partnership, Premas will connect with genomics labs to provide automated NGS solutions
An estimated 21 million American women experience BV
Arzeda harnesses the power of computer-designed enzymes and applies the latest advances in digital biology
The plant is scheduled to come on stream in September 2024
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
Technology Development Board supports commercialisation of Metal Injection Molding of implants
Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of Agili-C™ implant to the current surgical standard of care, debridement and microfracture in the knee joint
Tardive dyskinesia (TD) is a movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso and/or other body parts, which may be disruptive and negatively impact patients
Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project
Subscribe To Our Newsletter & Stay Updated
